Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | +8.71% |
|
-9.66% | -43.04% |
06-18 | NRx Pharmaceuticals, Inc. Appoints Dennis McBride to Its Board of Directors | CI |
06-03 | Certain Warrant of NRx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 3-JUN-2024. | CI |
Chart calendar NRx Pharmaceuticals, Inc.
Upcoming events on NRx Pharmaceuticals, Inc.
Past events on NRx Pharmaceuticals, Inc.
2024-06-27 07:00 | H.C. Wainwright Neuro Perspectives Virtual Conference |
2024-05-27 | American Society of Clinical Psychopharmacology Meeting |
2024-05-14 | EF Hutton Investor Conference |
2024-05-14 16:30 | Q1 2024 Earnings Call |
2024-05-14 16:01 | Q1 2024 Earnings Release |
2024-04-01 08:30 | Q4 2023 Earnings Call |
2024-04-01 08:28 | Q4 2023 Earnings Release |
2024-03-25 09:40 | Ketamine Conference |
2024-03-21 11:00 | Extraordinary Shareholders Meeting |
2024-02-26 14:30 | BIO CEO & Investor Conference |
2024-01-08 11:00 | LifeSci Partners Corporate Access Event |
2024-01-06 | Sachs Neuroscience Innovation Forum |
2023-12-19 11:00 | Annual General Meeting |
2023-12-04 16:30 | Noble Capital Markets Emerging Growth Equity Conference |
2023-11-14 16:30 | Q3 2023 Earnings Call |
2023-11-13 18:39 | Q3 2023 Earnings Release |
2023-10-12 16:00 | Dawson James Small Cap Growth Conference |
2023-09-21 09:15 | Sidoti Small Cap Conference |
2023-09-12 17:00 | H.C. Wainwright Global Investment Conference |
2023-08-14 16:30 | Q2 2023 Earnings Call |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -44,4 -43,8 -1.36% | -27,8 -29,6 5.8% | -24,0 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income Million USD | Released Forecast Spread | -93,1 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EPS USD | Released Forecast Spread | -74,4 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 31/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,60 -6,90 -39.13% | -9,14 -9,60 4.78% | -9,95 -9,40 -5.85% | -9,44 -9,00 -4.83% | -8,19 -9,65 15.15% | -5,81 -9,00 35.47% | -4,41 -6,15 28.36% | -6,00 -5,00 -19.96% | -6,00 | -6,00 | -6,00 | -5,00 | -5,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,53 -5,30 -23.17% | ||||||||||||
Net income Million USD | Released Forecast Spread | -6,53 -5,30 -23.17% | ||||||||||||
EPS USD | Released Forecast Spread | -0,74 -0,55 -34.55% | ||||||||||||
Announcement Date | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | 14/05/24 | - | - | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for NRx Pharmaceuticals, Inc.
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BRPA Stock
- Calendar NRx Pharmaceuticals, Inc.